May 9, 2017 | Brand Planning, Go To Market Strategy, Strategic planning, medical education, portfolio strategy

Timing is often the reason for embracing a new approach “this is ideal timing for our strategic planning”, yet can also be a major barrier for doing more of the same old thing “we really need to do things differently but timelines are pressing!”.
With huge demands on time and an industry where complexity and competition is rapidly increasing, finding the time to explore success from other industries and embrace new approaches is essential.
Our inspirational new approach, momentum strategy, is born out of academic research* and adapted to address the realities of the pharma industry.
Do you have the time to find out more?Momentum strategy is based on three spheres: discover, value and enable. These spheres create compelling insights, compelling value and compelling engagement.
The dynamic nature of this approach leads to increased connectivity, high energy and ongoing engagement, creating the ideal conditions for exceptional commercial growth.
If your business needs momentum or you want to know more, contact Duncan Ferguson, +44 (0)1494 755707, duncan@lucid-group.co.uk, or visit www.lucid-group.co.uk/strategic-consultancy
*Larreche JC. The momentum effect: how to ignite exceptional growth; Wharton School Publishing, 2008
This content was provided by Lucid Group Communications Limited
Company Details
Latest Content from Lucid Group Communications Limited
Appointment marks a pivotal step in Lucid’s next phase of growth, strengthening its ability to translate complex science into real-world impact. Lucid’s US Medical Affairs division unveils new proprietary insights…
Lucid Group announces the evolution of its consulting division, Lucid Strategy Consulting, setting a new standard for deep-domain, knowledge-led consulting solutions for life sciences. We have brought together two Lucid…
Working in Medical Communications has never been about the nine to five. Fusing science and language in the service of both clients and patients, this is typically a fast paced…
In April’s PME, Danny Buckland has been talking to industry leaders about launch excellence in the featured article, Listen, learn and lift off.Buckland points out that pandemic storms have changed the…
In the April edition of PME, Cheryl Harrison Doyle, Global Asset Strategy Director at Lucid Group discusses the need to take a more considered, outcomes-led approach when launching new medicines…
Meet our talent team, they’re here to help and transform your career.We have some exciting roles at all levels in account management and medical writing.If you choose to take your…
In support of Rare Disease Day, we’re excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so…
In support of Rare Disease Day, we’re excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so…
Rare Disease Day is all about raising awareness and generating change for the 300 million people worldwide living with a rare disease. The global rare disease community and its supporters come together on…
